A FLEXIBLE, USER FRIENDLY INTEGRATED
SOLUTION THAT DELIVERS DATA
SOLUTIONS ON-DEMAND FOR Pharmaceutical-biotechnology Medical-Device-Companies Contract-Research-Organizations Data-Management-Companies.

Sweet Shap

About Us

about hafl bg

What We Do

A complete one-stop solution to collect and manage all clinical trial information across all phases, therapeutic areas, magnitude or complexity of the studies.

An easy to use and cost-effective integrated solution that delivers data solutions on-demand for pharmaceutical, biotechnology, medical device companies, Contract Research Organizations and Data Management companies.

Our Solutions

  • RYGE-EDC
  • RYGE-CTMS
  • RYGE-IWRS
  • RYGE-PV
  • RYGE-eTMF
  • RYGE-ePRO
  • RYGE-rSDV
  • RYGE-eSURVEY
  • RYGE-eQMS
  • RYGE-eISF
  • RYGE-STMS
  • RYGE-RBQM

RYGE-EDC is ideal for all clinical trials regardless of phase, therapeutic areas, magnitude or complexity.

RYGE-CTMS is a web enabled clinical trial management system that supports to view and manage real-time operational performance.

RYGE-IWRS is a web enabled interactive web response system for managing study randomization and supply management solutions.

RYGE-PV is compliant to EMA and FDA regulatory requirements and is aligned to ICH GCP.

RYGE-eTMF covers full document life cycle from document creation to document review, approval and validation.

RYGE-ePRO is a web-based system that helps for instant data capture from patients and transfer to a centralized data center from anywhere in the world.

The coronavirus disease 2019 (COVID-19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials.

RYGE-eSURVEY — we are coming soon.

RYGE-eQMS — we are coming soon.

RYGE-eISF — we are coming soon.

RYGE-STMS — we are coming soon.

RYGE-RBQM — we are coming soon.

about hafl bg

MAKE AN SCHEDULE DEMO

Schedule a demo with our team of experts

Please complete the form below and a member of our team will be in touch within one business day.

1000

Users

7

Countries

30

Studies

7000

Study Participants